Catalyst Funds Management
ELAN icon

Catalyst Funds Management’s Elanco Animal Health ELAN Stock Holding History

Catalyst Funds Management’s Portfolio ELAN Stock Details ELAN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		– Sell
-9,850
Closed -$242K – 687
2026
Q2 		$242K Buy
+9,850
New +$228K 0.01% 546
2025
Q3 		– Sell
-44,900
Closed -$641K – 540
2025
Q2 		$641K Sell
44,900
-159,100
-78% -$1.86M 0.18% 158
2025
Q1 		$2.14M Buy
+204,000
New +$2.31M 0.56% 47

Other funds holding ELAN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $187B AUM 13.73% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $161B AUM 86.05% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Black Creek Investment Management
Black Creek Investment Management Toronto, Ontario, Canada $1.8B AUM 5.03% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $114B AUM 35.47% 1-Year Est. Return

Catalyst Funds Management's ELAN Position: Q3 2026 in Review

Catalyst Funds Management sold out of Elanco Animal Health (ELAN) in Q3 2026, closing a stake of 9,850 shares — an estimated $242K sold.

Catalyst Funds Management first reported a position in ELAN in Q1 2025 and held it in 3 quarters. The position peaked at $2.14M in Q1 2025. 423 funds tracked by Wall St. Rank hold ELAN as of Q3 2026.

  • Catalyst Funds Management reported no remaining Elanco Animal Health position as of Q3 2026 after selling out during the quarter.
  • Catalyst Funds Management sold 9,850 Elanco Animal Health shares in Q3 2026, an estimated $242K.
  • Catalyst Funds Management first reported a position in Elanco Animal Health in Q1 2025 and held it in 3 quarters.
  • Catalyst Funds Management's Elanco Animal Health position peaked at $2.14M in Q1 2025.
  • 423 funds tracked by Wall St. Rank held Elanco Animal Health as of Q3 2026.

Based on Catalyst Funds Management's 13F filing for Q3 2026, filed 12 Nov 2026.